Anúncio
Anúncio
CRVS
Corvus Pharmaceuticals, Inc.
6.79
USDPatrocinado
-0.13
-1.94%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
6.85
+0.06
+0.94%
Relatórios de Lucros CRVS
Rácio de surpresa positiva
CRVS separação 22 de 39 últimas estimativas.
56%
Próximo Relatório
Data do Próximo Relatório
23 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.13
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+8.33%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-27.78%
Corvus Pharmaceuticals, Inc. earnings per share and revenue
On 04 de nov. de 2025, CRVS reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.13 USD, resulting in a 11.83% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.44% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an aumentar of 8.33% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Corvus Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Corvus Pharmaceuticals, Inc. reported EPS of -$0.12, beating estimates by 11.83%, and revenue of $0.00, 0% as expectations.
How did the market react to Corvus Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -1.44%, changed from $7.64 before the earnings release to $7.53 the day after.
When is Corvus Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 23 de mar. de 2026.
What are the forecasts for Corvus Pharmaceuticals, Inc.'s next earnings report?
Based on 9
analistas, Corvus Pharmaceuticals, Inc. is expected to report EPS of -$0.13 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio